Save time and get answers to complex questions with AI chat
The expiration date of the key patent for guselkumab?Norcuron generic name?How does iron rich food intake impact lipitor's efficacy?Patent expiry trametinib?Combivent generic equivalent?
See the DrugPatentWatch profile for Xarelto
Xarelto (rivaroxaban) was approved by the U.S. FDA on July 1, 2011. [1]
At approval, Xarelto was indicated for reducing the risk of stroke and systemic embolism in nonvalvular atrial fibrillation, along with other initial indications listed at launch in the FDA approval materials. [1]
[1] https://www.drugpatentwatch.com/p/xarelto
Other Questions About Xarelto :